BACKGROUND: Reported early complication rates in reverse total shoulder arthroplasty have widely varied from 0% to 75% in part due to a lack of standard inclusion criteria. In addition, it is unclear whether revision arthroplasty is associated with a higher rate of complications than primary arthroplasty. QUESTIONS/ PURPOSE: We therefore (1) determined the types and rates of early complications in reverse total shoulder arthroplasty using defined criteria, (2) characterized an early complication-based learning curve for reverse total shoulder arthroplasty, and (3) determined whether revision arthroplasties result in a higher incidence of complications. PATIENTS AND METHODS: From October 2004 to May 2008, an initial series of 200 reverse total shoulder arthroplasties was performed in 191 patients by a single surgeon. Forty of the 200 arthroplasties were revision arthroplasties. Of these, 192 shoulders were available for minimum 6-month followup (mean, 19.4 months; range, 6-49.2 months). We determined local and systemic complications and distinguished major from minor complications. RESULTS: Nineteen shoulders involved local complications (9.9%), including seven major and 12 minor complications. Nine involved perioperative systemic complications (4.7%), including eight major complications and one minor complication. The local complication rate was higher in the first 40 shoulders (23.1%) versus the last 160 shoulders (6.5%). Seven of 40 (17.5%) revision arthroplasties involved local complications, including two major and five minor complications compared to 12 of 152 (7.9%) primary arthroplasties, including five major and seven minor complications. Nerve palsies occurred less frequently in primary arthroplasties (0.6%) compared to revisions (9.8%). CONCLUSIONS: The early complication-based learning curve for reverse total shoulder arthroplasty is approximately 40 cases. There was a trend toward more complications in revision versus primary reverse total shoulder arthroplasty and more neuropathies in revisions. LEVEL OF EVIDENCE: Level IV, therapeutic study. See the guidelines online for a complete description of level of evidence.
BACKGROUND: Reported early complication rates in reverse total shoulder arthroplasty have widely varied from 0% to 75% in part due to a lack of standard inclusion criteria. In addition, it is unclear whether revision arthroplasty is associated with a higher rate of complications than primary arthroplasty. QUESTIONS/ PURPOSE: We therefore (1) determined the types and rates of early complications in reverse total shoulder arthroplasty using defined criteria, (2) characterized an early complication-based learning curve for reverse total shoulder arthroplasty, and (3) determined whether revision arthroplasties result in a higher incidence of complications. PATIENTS AND METHODS: From October 2004 to May 2008, an initial series of 200 reverse total shoulder arthroplasties was performed in 191 patients by a single surgeon. Forty of the 200 arthroplasties were revision arthroplasties. Of these, 192 shoulders were available for minimum 6-month followup (mean, 19.4 months; range, 6-49.2 months). We determined local and systemic complications and distinguished major from minor complications. RESULTS: Nineteen shoulders involved local complications (9.9%), including seven major and 12 minor complications. Nine involved perioperative systemic complications (4.7%), including eight major complications and one minor complication. The local complication rate was higher in the first 40 shoulders (23.1%) versus the last 160 shoulders (6.5%). Seven of 40 (17.5%) revision arthroplasties involved local complications, including two major and five minor complications compared to 12 of 152 (7.9%) primary arthroplasties, including five major and seven minor complications. Nerve palsies occurred less frequently in primary arthroplasties (0.6%) compared to revisions (9.8%). CONCLUSIONS: The early complication-based learning curve for reverse total shoulder arthroplasty is approximately 40 cases. There was a trend toward more complications in revision versus primary reverse total shoulder arthroplasty and more neuropathies in revisions. LEVEL OF EVIDENCE: Level IV, therapeutic study. See the guidelines online for a complete description of level of evidence.
Authors: Jacques Guery; Luc Favard; François Sirveaux; Didier Oudet; Daniel Mole; Gilles Walch Journal: J Bone Joint Surg Am Date: 2006-08 Impact factor: 5.284
Authors: Mark Frankle; Steven Siegal; Derek Pupello; Arif Saleem; Mark Mighell; Matthew Vasey Journal: J Bone Joint Surg Am Date: 2005-08 Impact factor: 5.284
Authors: Richard A Deyo; Sohail K Mirza; Brook I Martin; William Kreuter; David C Goodman; Jeffrey G Jarvik Journal: JAMA Date: 2010-04-07 Impact factor: 56.272
Authors: Brett P Wiater; Denise M Koueiter; Tristan Maerz; James E Moravek; Samuel Yonan; David R Marcantonio; J Michael Wiater Journal: Clin Orthop Relat Res Date: 2014-11-12 Impact factor: 4.176
Authors: Christine C Johnson; Sonal Sodha; Juan Garzon-Muvdi; Steve A Petersen; Edward G McFarland Journal: Clin Orthop Relat Res Date: 2013-12-10 Impact factor: 4.176
Authors: Julian J Prokopetz; Jeffrey N Katz; Elena Losina; Thomas S Thornhill; John Wright; Lisa Soleymani Lehmann Journal: Arthritis Care Res (Hoboken) Date: 2013-01 Impact factor: 4.794
Authors: Sebastian Orman; Amin Mohamadi; Joseph Serino; Jordan Murphy; Philip Hanna; Michael J Weaver; George Dyer; Ara Nazarian; Arvind von Keudell Journal: Shoulder Elbow Date: 2019-02-28
Authors: Edward J Testa; Jeremiah T Lowe; Surena Namdari; Robert J Gillespie; Benjamin W Sears; Peter S Johnston; Andrew Jawa Journal: Shoulder Elbow Date: 2018-11-14